Literature DB >> 17708508

Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.

A Capone1, M Valle, F Proietti, O Federici, A Garofalo, N Petrosillo.   

Abstract

BACKGROUND: Peritoneal carcinomatosis is a common evolution of many abdominal and pelvic malignancies. Over the last decade novel therapeutic approaches have emerged combining cytoreductive surgery with perioperative intraperitoneal chemotherapy. Aim of our study was to assess frequency, sites, and organisms of postoperative infections in this surgery and to evaluate associated risk factors and clinical outcome.
METHODS: Retrospective study of postoperative infection in 30 patients undergoing combined cytoreductive surgery and hypertermic intraoperative chemotherapy in an oncologic surgery in Rome, between June 2001 and December 2004.
RESULTS: Twenty-nine postoperative infections were recorded in 11 patients (36.7%; 2.6 infections per patient), including 13 surgical site infections, 8 clinical sepsis, 6 bloodstream infections, and 2 pneumonias. At multivariate analysis, total peritonectomy was found as independent variable associated to postoperative infection. Mortality rates were 36.4% and 5% among patients with and without postoperative infections, respectively (P = 0.04). Four of the 5 patients with invasive candidosis died.
CONCLUSIONS: Peritonectomy procedures have an high risk of postoperative infections, prolonged hospital stay, and high morbidity and mortality. The increasing role of this surgery for the treatment of peritoneal carcinomatosis should strengthen the need for a careful evaluation of possible risk factors for postoperative infections, including the role of colonizing organisms.

Entities:  

Mesh:

Year:  2007        PMID: 17708508     DOI: 10.1002/jso.20837

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases.

Authors:  Sanket S Mehta; Maxilliano Gelli; Deepesh Agarwal; Diane Goéré
Journal:  Indian J Surg Oncol       Date:  2016-02-10

2.  Does Intraoperative Systematic Bacterial Sampling During Complete Cytoreductive Surgery (CRS) with Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) Influence Postoperative Treatment? A New Predictive Factor for Postoperative Abdominal Infectious Complications.

Authors:  Marie Dazza; Lilian Schwarz; Julien Coget; Noelle Frebourg; Gregory Wood; Emmanuel Huet; Valérie Bridoux; Benoit Veber; Jean-Jacques Tuech
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

3.  Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?

Authors:  Cem Terzi; Naciye Cigdem Arslan; Aras Emre Canda
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.

Authors:  Ning Miao; James F Pingpank; H Richard Alexander; Richard Royal; Seth M Steinberg; Martha M Quezado; Tatiana Beresnev; Zenaide M N Quezado
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

5.  Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Guus P Leijte; Hettie Custers; Jelle Gerretsen; Amon Heijne; Johannes Roth; Thomas Vogl; Gert J Scheffer; Peter Pickkers; Matthijs Kox
Journal:  Front Immunol       Date:  2018-04-05       Impact factor: 7.561

6.  Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center.

Authors:  Maurizio Cardi; Simone Sibio; Francesco Di Marzo; Francesco Lefoche; Claudia d'Agostino; Giovanni Battista Fonsi; Giuseppe La Torre; Ludovica Carbonari; Paolo Sammartino
Journal:  Gastroenterol Res Pract       Date:  2019-05-02       Impact factor: 2.260

7.  Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study.

Authors:  Talat A M Albukhari; Hanaa Nafady-Hego; Hamed Elgendy; Hanan M Abd Elmoneim; Asmaa Nafady; Abdulaziz M Alzahrani
Journal:  Int J Microbiol       Date:  2019-08-01

8.  Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients.

Authors:  Vinicius Preti; David Chang; Paul H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-08-13       Impact factor: 2.260

9.  Antibiotic Prophylaxis for Surgical Site Infection in General Surgery: Oncological Treatments and HIPEC.

Authors:  Carlo Vallicelli; Federico Coccolini; Massimo Sartelli; Luca Ansaloni; Simona Bui; Fausto Catena
Journal:  Antibiotics (Basel)       Date:  2021-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.